Adcetris (Brentuximab vedotin)Brand Name: Adcetris
Active Ingredient: Brentuximab vedotin
Dosage Form: 150mg / vial
Manufacturer Name: Takeda
Why is Brentuximab Vedotin prescribed?
Patients with Hodgkin’s lymphoma (Hodgkin’s disease) who have not previously had treatment, as well as those who are vulnerable to the condition getting worse or coming back after a stem cell transplant, are treated with injections of brentuximab vedotin together with other chemotherapy medications which is a procedure that replaces diseased bone marrow with healthy bone marrow.
A monoclonal antibody, or kind of protein, found in the Adcetris active ingredient, brentuximab vedotin, binds to CD30 and the cytotoxic (cell-killing) chemical monomethyl auristatin E. To treat leukemias that are CD30-positive, monoclonal antibodies produce monomethyl auristatin E.
The suggested dosage is 1.8 mg/kg given as a 30-minute intravenous infusion every three weeks. Before administering each dose of this medicine, complete blood counts should be checked. Patients need to be examined both during and after an infusion.
Who should not take Brentuximab Vedotin?
If you’re unsure, speak with your doctor.
What are the possible side effects of Brentuximab Vedotin?
Special Precautions For Kineret
Shelf life of Brentuximab Vedotin injection: Four years.
We offer affordable access to adcetris injection in Dubai with ease and speed. Depending on the customer’s needs, we provide a quality guarantee and shipping anywhere in the world.
Please schedule a consultation with us by calling us at +971 54 777 1238 or +971 55 223 1090 or email us at [email protected] to know how much Brentuximab Vedotin injection costs in Dubai. Our helpful team would be happy to assist you and provide any general or medical information.